Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism ERs agonists(Estrogen receptors agonists), PR agonists(Progesterone receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H28O3 |
InChIKeyIMONTRJLAWHYGT-ZCPXKWAGSA-N |
CAS Registry51-98-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Oestrogen deficiency | Phase 2 | United States | - |